Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan L Marks

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Medicine (London, England)|April 3, 2016
Viral arthritisMichael Marks, Jonathan L Marks
Therapeutic Advances in Musculoskeletal Disease|August 2, 2012
Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidityJonathan L Marks, Christopher J Edwards
Journal of the Royal Society of Medicine|February 2, 2010
Response: cricoarytenoid arthritis presenting as croupJonathan L Marks, Sandeep Mukherjee, Richard G Hull
Clinical Medicine (London, England)|August 24, 2010
Failure in prescribed medications being given to inpatientsJonathan L Marks, Sandeep Mukherjee, Richard G Hull
The Cochrane Database of Systematic Reviews|November 11, 2011
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)Alexandra N Colebatch, Jonathan L Marks, Christopher J Edwards
The Cochrane Database of Systematic Reviews|October 7, 2011
Pain management for rheumatoid arthritis and cardiovascular or renal comorbidityJonathan L Marks, Alexandra N Colebatch, Rachelle Buchbinder, et al.
Eating and Weight Disorders : EWD|October 13, 2017
Comparing the effectiveness of general dietary advice versus a very low energy diet in an obese outpatient population in AustraliaRebecca L Venchiarutti, Karen Byth, Jonathan L Marks, et al.
The Journal of Rheumatology. Supplement|September 4, 2012
Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic reviewAlexandra N Colebatch, Jonathan L Marks, Désirée M van der Heijde, et al.
The Journal of Rheumatology. Supplement|September 4, 2012
Pain pharmacotherapy in patients with inflammatory arthritis and concurrent cardiovascular or renal disease: a Cochrane systematic reviewJonathan L Marks, Désirée M van der Heijde, Alexandra N Colebatch, et al.
Arthritis Care & Research|January 22, 2015
Does combined clinical and ultrasound assessment allow selection of individuals with rheumatoid arthritis for sustained reduction of anti-tumor necrosis factor therapy?Jonathan L Marks, Christopher R Holroyd, Borislav D Dimitrov, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Medicine (London, England)|April 3, 2016
Viral arthritisMichael Marks, Jonathan L Marks
Therapeutic Advances in Musculoskeletal Disease|August 2, 2012
Protective effect of methotrexate in patients with rheumatoid arthritis and cardiovascular comorbidityJonathan L Marks, Christopher J Edwards
Journal of the Royal Society of Medicine|February 2, 2010
Response: cricoarytenoid arthritis presenting as croupJonathan L Marks, Sandeep Mukherjee, Richard G Hull
Clinical Medicine (London, England)|August 24, 2010
Failure in prescribed medications being given to inpatientsJonathan L Marks, Sandeep Mukherjee, Richard G Hull
The Cochrane Database of Systematic Reviews|November 11, 2011
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis)Alexandra N Colebatch, Jonathan L Marks, Christopher J Edwards
The Cochrane Database of Systematic Reviews|October 7, 2011
Pain management for rheumatoid arthritis and cardiovascular or renal comorbidityJonathan L Marks, Alexandra N Colebatch, Rachelle Buchbinder, et al.
Eating and Weight Disorders : EWD|October 13, 2017
Comparing the effectiveness of general dietary advice versus a very low energy diet in an obese outpatient population in AustraliaRebecca L Venchiarutti, Karen Byth, Jonathan L Marks, et al.
The Journal of Rheumatology. Supplement|September 4, 2012
Safety of nonsteroidal antiinflammatory drugs and/or paracetamol in people receiving methotrexate for inflammatory arthritis: a Cochrane systematic reviewAlexandra N Colebatch, Jonathan L Marks, Désirée M van der Heijde, et al.
The Journal of Rheumatology. Supplement|September 4, 2012
Pain pharmacotherapy in patients with inflammatory arthritis and concurrent cardiovascular or renal disease: a Cochrane systematic reviewJonathan L Marks, Désirée M van der Heijde, Alexandra N Colebatch, et al.
Arthritis Care & Research|January 22, 2015
Does combined clinical and ultrasound assessment allow selection of individuals with rheumatoid arthritis for sustained reduction of anti-tumor necrosis factor therapy?Jonathan L Marks, Christopher R Holroyd, Borislav D Dimitrov, et al.
Pageof 2